Genmab — September 2018
-
hvordan forstår du så dette gentogen.All the eligible participants will be randomly assigned to receive either daratumumab in combination with lenalidomide and dexamethasone (DRd) or lenalidomide and dexamethasone (Rd). Daratumumab (16 milligram per kilogram [mg/kg]) will be administered weekly for first 8 weeks (Cycles 1 to 2) of treatment and then every other week for 16 weeks (Cycles 3 to 6), then every 4 weeks (from Cycle 7 and beyond) until progression of disease or unacceptable toxicity
-
Du har ret jkj. Jeg var lige inde og kigge på rettelserne fra juni sidste år. Før stod der at DRd-armen ville modtage Rd (altså ud over D) i højst 2 år. Nå står der at de fortsætter med at modtage Rd (ud over D) indtil progression. Så der er altså ikke noget med at de overgår til vedligeholdelse med Rd. Beklager.
-
Jeg lyttede lige til Wells Fargo’s webcast med Alex Gorsky fra J&J. Darzalex blev nævnt some core brand og han nævnte fremtidige line extensions (some billion dollar). Pharma står som en stor del af deres business. Der blev spurgt om hvorfor de havde lagt et pharma investor call den 13 sep, når de kun plejede at gøre det ifm earnings. Han svarede at nu var det pharma’s tur. Webcastet can genhøres her https://event.webcasts.com/viewer/event.jsp?ei=1204025&tp_key=b2d014b7f8
-
Hvor så i de udsving henne?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind